Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 23% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 27% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2427.85 | 2642 / 2642 | 100% | 15.07 | 705 / 705 |
breast | 100% | 2272.88 | 459 / 459 | 100% | 17.21 | 1118 / 1118 |
esophagus | 100% | 1793.78 | 1445 / 1445 | 100% | 15.13 | 183 / 183 |
intestine | 100% | 2065.12 | 966 / 966 | 100% | 17.45 | 527 / 527 |
liver | 100% | 1612.43 | 226 / 226 | 100% | 10.04 | 406 / 406 |
lung | 100% | 2205.34 | 578 / 578 | 100% | 14.86 | 1155 / 1155 |
ovary | 100% | 2438.89 | 180 / 180 | 100% | 16.93 | 430 / 430 |
pancreas | 100% | 2467.45 | 328 / 328 | 100% | 11.72 | 178 / 178 |
prostate | 100% | 2255.04 | 245 / 245 | 100% | 13.44 | 502 / 502 |
stomach | 100% | 1681.78 | 359 / 359 | 100% | 17.17 | 286 / 286 |
thymus | 100% | 2495.11 | 653 / 653 | 100% | 12.99 | 604 / 605 |
bladder | 100% | 2079.29 | 21 / 21 | 100% | 15.45 | 503 / 504 |
uterus | 100% | 2194.13 | 170 / 170 | 100% | 14.25 | 458 / 459 |
kidney | 100% | 2478.52 | 89 / 89 | 100% | 13.78 | 898 / 901 |
skin | 100% | 2424.20 | 1809 / 1809 | 100% | 14.83 | 470 / 472 |
adrenal gland | 100% | 2333.50 | 258 / 258 | 99% | 10.90 | 228 / 230 |
adipose | 100% | 2284.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.95 | 29 / 29 |
spleen | 100% | 2332.30 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.65 | 1 / 1 |
blood vessel | 100% | 1602.67 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1178.11 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1102.30 | 850 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 9.85 | 77 / 80 |
peripheral blood | 96% | 1473.24 | 892 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070681 | Biological process | glutaminyl-tRNAGln biosynthesis via transamidation |
GO_0032543 | Biological process | mitochondrial translation |
GO_0006450 | Biological process | regulation of translational fidelity |
GO_0030956 | Cellular component | glutamyl-tRNA(Gln) amidotransferase complex |
GO_0005739 | Cellular component | mitochondrion |
GO_0050567 | Molecular function | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | GATC |
Protein name | Glutamyl-tRNA amidotransferase subunit C Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Glu-AdT subunit C) (EC 6.3.5.-) (Protein 15E1.2) |
Synonyms | 15E1.2 |
Description | FUNCTION: Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in the mitochondria. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu-tRNA(Gln). . |
Accessions | ENST00000548171.1 J3KMY1 ENST00000229384.5 O43716 F8VRU3 ENST00000551765.6 |